Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy Academic Article uri icon

Overview

MeSH Major

  • Allopurinol
  • Cardiomyopathy, Dilated
  • Enzyme Inhibitors
  • Ventricular Dysfunction, Left

abstract

  • These findings indicate that XO activity may contribute to abnormal energy metabolism in human cardiomyopathy. By reversing the energetic inefficiency of the failing heart, pharmacological XO inhibition represents a potential novel therapeutic strategy for the treatment of human heart failure.

publication date

  • November 13, 2001

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 11705816

Additional Document Info

start page

  • 2407

end page

  • 11

volume

  • 104

number

  • 20